278 related articles for article (PubMed ID: 21854628)
1. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
Li H; Baldwin BR; Zahnow CA
Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.
Baldwin BR; Timchenko NA; Zahnow CA
Mol Cell Biol; 2004 May; 24(9):3682-91. PubMed ID: 15082764
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functions.
Saint-Auret G; Danan JL; Hiron M; Blache C; Sulpice E; Tendil S; Daveau M; Gidrol X; Salier JP
J Hepatol; 2011 Jun; 54(6):1185-94. PubMed ID: 21145827
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.
Derer S; Berger S; Schlaeth M; Schneider-Merck T; Klausz K; Lohse S; Overdijk MB; Dechant M; Kellner C; Nagelmeier I; Scheel AH; Lammerts van Bueren JJ; van de Winkel JG; Parren PW; Peipp M; Valerius T
Neoplasia; 2012 Mar; 14(3):190-205. PubMed ID: 22496619
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3.
Piwien-Pilipuk G; Van Mater D; Ross SE; MacDougald OA; Schwartz J
J Biol Chem; 2001 Jun; 276(22):19664-71. PubMed ID: 11278638
[TBL] [Abstract][Full Text] [Related]
8. Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.
Fields J; Cisneros IE; Borgmann K; Ghorpade A
PLoS One; 2013; 8(2):e56891. PubMed ID: 23457635
[TBL] [Abstract][Full Text] [Related]
9. Role of C/EBPβ-LAP and C/EBPβ-LIP in early adipogenic differentiation of human white adipose-derived progenitors and at later stages in immature adipocytes.
Lechner S; Mitterberger MC; Mattesich M; Zwerschke W
Differentiation; 2013 Jan; 85(1-2):20-31. PubMed ID: 23314288
[TBL] [Abstract][Full Text] [Related]
10. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.
Arnal-Estapé A; Tarragona M; Morales M; Guiu M; Nadal C; Massagué J; Gomis RR
Cancer Res; 2010 Dec; 70(23):9927-36. PubMed ID: 21098707
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 and C/EBPβ LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
Liu Q; Boudot A; Ni J; Hennessey T; Beauparlant SL; Rajabi HN; Zahnow C; Ewen ME
Mol Cell Biol; 2014 Aug; 34(16):3168-79. PubMed ID: 24912680
[TBL] [Abstract][Full Text] [Related]
12. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
Li M; Chiu JF; Gagne J; Fukagawa NK
J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
[TBL] [Abstract][Full Text] [Related]
15. P53 regulates CCAAT/Enhancer binding protein β gene expression.
Hu B; Liu T; Wu Z; Phan SH
Gene; 2023 Oct; 884():147675. PubMed ID: 37541559
[TBL] [Abstract][Full Text] [Related]
16. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
[TBL] [Abstract][Full Text] [Related]
17. Selenium modulates AR/IGF-1R/EGFR and TROP2 signaling pathways and improves anticancer efficacy in murine mammary carcinoma 4T1.
Guo CH; Wang SY; Chung CH; Shih MY; Li WC; Chen PC; Lee SY; Hsia S
J Nutr Biochem; 2023 Oct; 120():109417. PubMed ID: 37482256
[TBL] [Abstract][Full Text] [Related]
18. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
Ravid D; Maor S; Werner H; Liscovitch M
Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
[TBL] [Abstract][Full Text] [Related]
20. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
Bundy L; Wells S; Sealy L
Mol Cancer; 2005 Dec; 4():43. PubMed ID: 16371159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]